Next Article in Journal
Age-Specific Excretion of Calcium, Oxalate, Citrate, and Glycosaminoglycans and Their Ratios in Healthy Children and Children with Urolithiasis
Next Article in Special Issue
Molecular Dynamics Simulations of Human FOXO3 Reveal Intrinsically Disordered Regions Spread Spatially by Intramolecular Electrostatic Repulsion
Previous Article in Journal
Sweet Modifications Modulate Plant Development
Previous Article in Special Issue
Structural Analysis of the cl-Par-4 Tumor Suppressor as a Function of Ionic Environment
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biomolecules
Volume 11
Issue 5
10.3390/biom11050757
biomolecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Protein–Protein Connections—Oligomer, Amyloid and Protein Complex—By Wide Line 1H NMR

by
Mónika Bokor
1,* and
Ágnes Tantos
2
1
Wigner Research Centre for Physics, Institute for Solid State Physics and Optics, 1121 Budapest, Hungary
2
Research Centre for Natural Sciences, Institute of Enzymology, 1117 Budapest, Hungary
*
Author to whom correspondence should be addressed.
Biomolecules 2021, 11(5), 757; https://doi.org/10.3390/biom11050757
Submission received: 17 March 2021 / Revised: 29 April 2021 / Accepted: 14 May 2021 / Published: 18 May 2021
(This article belongs to the Special Issue The Amazing World of IDPs in Human Diseases II)
Browse Figures
Review Reports Versions Notes

Abstract

:
The amount of bonds between constituting parts of a protein aggregate were determined in wild type (WT) and A53T α-synuclein (αS) oligomers, amyloids and in the complex of thymosin-β4–cytoplasmic domain of stabilin-2 (Tβ4-stabilin CTD). A53T αS aggregates have more extensive βsheet contents reflected by constant regions at low potential barriers in difference (to monomers) melting diagrams (MDs). Energies of the intermolecular interactions and of secondary structures bonds, formed during polymerization, fall into the 5.41 kJ mol−1 ≤ Ea ≤ 5.77 kJ mol−1 range for αS aggregates. Monomers lose more mobile hydration water while forming amyloids than oligomers. Part of the strong mobile hydration water–protein bonds break off and these bonding sites of the protein form intermolecular bonds in the aggregates. The new bonds connect the constituting proteins into aggregates. Amyloid–oligomer difference MD showed an overall more homogeneous solvent accessible surface of A53T αS amyloids. From the comparison of the nominal sum of the MDs of the constituting proteins to the measured MD of the Tβ4-stabilin CTD complex, the number of intermolecular bonds connecting constituent proteins into complex is 20(1) H2O/complex. The energies of these bonds are in the 5.40(3) kJ mol−1 ≤ Ea ≤ 5.70(5) kJ mol−1 range.

1. Introduction

One of the main reasons intrinsically disordered proteins (IDPs) are so important in different physiological processes is that they are capable of forming a bewildering variety of interactions. They can undergo induced folding or unfolding, they are able to form physiological or pathological aggregates, and even form fuzzy complexes, where disorder is retained during the interaction [1]. Describing the molecular details of the different interaction types of IPDs is crucial for the clear understanding their mechanisms of function and for the interference with the pathological processes caused by their erroneous behavior.
In our work presented here, two IDP interaction systems were studied to gain information about the bonds holding the protein associations—oligomer, amyloid, and complex—together. One system contains wild type and mutant α-synuclein (αS) in the forms of oligomers and amyloids. Detailed structural and preparation information can be found in [2,3]. The other system consists of two proteins—thymosin-β4 (Tβ4) and cytoplasmic domain of stabilin-2 (stabilin CTD)—which form a 1:1 complex (see [4,5] for structural information and for details of preparation).
αS is a 140-amino-acid protein mainly located at presynaptic terminals and is abundant in the brain [6]. The exact physiological role of αS remains unclear, but it’s thought to be involved in the regulation of synaptic vesicle mobility [7] through binding to VAMP [8]. Pathological aggregation of αS is the leading cause of Parkinson’s disease (PD), and some mutations of αS, such as A53T, cause familial occurrences of the disease [9,10]. A53T mutation results in faster αS accumulation [11]. When the balance between the production and clearance of αS is disturbed, the monomeric αS aggregates and misfolds into oligomers, then amyloid fibrils and finally Lewy bodies [12]. The exact pathogenesis of PD is still unknown, but more and more evidence suggests that the oligomeric form of αS plays a vital part in the pathogenesis of PD [12,13,14,15,16]. Historically, αS has been considered as an IDP in the healthy, physiological state [17,18]. IDPs exist as dynamic protein ensembles with fluxional structures under physiological conditions that can adopt different conformations depending on their external stimuli, thus enabling the complex signaling and regulatory requirements of higher biological systems [19,20].
The structural traits that lie behind the stronger amyloidogenic propensity of the disease-related mutants are intensively studied and have revealed many important features. The helical content of wild type (WT) αS is minimally affected by the A53T mutation, while there is an increase in the β-sheet content of the A53T mutant-type in comparison to the WT protein [18,21,22,23,24]. Long-range intramolecular interactions between the different regions either are less abundant or disappear upon A53T mutation [25,26,27], indicating that the NAC (non-AB component) region is more solvent-exposed upon A53T mutation [28]. As this segment is indispensable for the amyloid formation, its easier accessibility explains the increased aggregation propensity of the A53T mutant [22,23,26,29,30,31,32,33]. The structures of the A53T αS are thermodynamically more preferred than the structures of the WT αS [26].
Our understanding of amyloid structure lately has been improved a lot by innovations in cryo-electron microscopy, electron diffraction and solid-state NMR. The results show expected cross-β amyloid structure and an unexpectedly diverse and complex amyloid fold [34]. The amyloid cores are constituted of extensive mainchain hydrogen bonding between adjacent β-strands within the stacked layers, and close interdigitation of sidechains. The amyloid fibrils are dynamic, with monomers and/or oligomers dissociating from their ends [35,36].
Isolated Tβ4, stabilin CTD and their 1:1 complex create a system where the bonds formed in the complex can be studied.
Tβ4 is an IDP with moonlighting functions. It can sequester actin [37] and it has important role in the regulation of the formation and modulation of the actin cytoskeleton [38]. Many different functions were attributed to Tβ4. Such functions are, e.g., endothelial cell differentiation [39], angiogenesis [40] and wound repair [41]. Tβ4 can increase the concentration of metalloproteinases, which is important in cell migration [41], the underlying process of which is still unclear. The multiple functions of Tβ4 are probably related to that, it is an IDP and has very little transient secondary structure in solution phase [42]. It binds often weakly to its physiological partners, and forms structurally heterogeneous complexes with them [43], but it can fold upon binding.
Stabilin-2 is an endocytic receptor for hyaluronic acid, and its C-terminal domain (CTD) binds Tβ4 [4,44]. The observation that Tβ4 colocalizes with stabilin-2 in the phagocytic cup suggests that the complex of Tβ4 with stabilin-2 CTD is involved in the phagocytosis of apoptotic cells [45]. It was also shown that knockdown or overexpression of Tβ4 decreased and enhanced the phagocytic activity of stabilin-2, respectively. While the exact molecular mechanism of this is yet unclear, it was found that Tβ4 engages in multiple fuzzy interactions with stabilin-2 CTD. It is capable of mediating its distinct yet specific interactions without adapting distinct folded structures in the different complexes [42]. Weak binding was confirmed between Tβ4 and stabilin-2 CTD and it was suggested that the proteins become slightly more disordered in the complex [4,5].
The purpose of this experimental study is to determine the amount and quality of bonds between constituting parts of a protein aggregate in wild type (WT) and A53T α-synuclein (αS) oligomers, amyloids and in the complex of thymosin-β4–cytoplasmic domain of stabilin-2. The selection of the studied proteins represents a system in which the constituents are different in their degree of polymerization and another system where the constituents interact with each other. This work presents as novelty compared to the previous works [2,3,4,5] the differences between α-Ss of different degrees of polymerization and sheds light on the bonds between the constituting proteins in the Tβ4-stabilin CTD complex.

2. Materials and Methods

The studied proteins were prepared, and their qualities were checked as in [2,3,4,5]. Briefly, untagged versions of α-synuclein variants were expressed in E. coli cells and purified using anion exchange chromatography, while stabilin CTD was expressed with an N-terminal His-tag and purified on a Ni-NTA affinity column. The wide-line 1H NMR signals (see Appendix A and Supporting Information of [3]) on the time scale are composed of more components of different origins (ice, protein, mobile water) and time constants. The intensities of the components with the longest decaying-time constants give the amounts of the mobile hydration water. Melting diagrams (MDs) are the relative amounts of the proteins’ mobile water measured by intensities of wide-line 1H NMR signals vs. normalized functional temperature. The mobile hydration differences were calculated from MDs of WT and A53T αS monomers, oligomers and amyloids in [3], and from MDs of Tβ4, stabilin-2 CTD and their 1:1 complex in [4,5]. In this work, potential barriers corresponding to normalized functional temperature are used. Potential barriers are calculated from functional (or absolute) temperature by first normalizing it with the melting point of water (273.15 K) and then scaling this normalized temperature with the melting heat of ice (Q = 6.01 kJ mol−1), Ea = T·Q/Tm, where T is the absolute temperature and Tm is the melting point of water. The relative amount of mobile water is converted to molar amount of mobile water per amino acid residues, naa. The MDs are given as naa vs. Ea. The motion of water is controlled by the potential barrier.

3. Results

3.1. The α-Synuclein System

Mobile hydration differences (monomer MD subtracted from oligomer (o-m) and amyloid (a-m) MDs) were calculated for αS variants of different polymerization degrees. The difference MDs for the o-m and the a-m cases are very similar for each variant (Figure 1).
The derivative ratios are depicted in the insets of the figures and they reflect very sensitively the changes in the trends of the melting curves. However, they have characteristically different shapes for the WT and the A53T variants. While the WT αS o-m difference MD has two sections with distinct slopes, A53T αS has three. The additional low-potential-barrier (Ea) sections in A53T difference curves can be attributed to the excess β-sheet contents [22,23,24,25] of the mutant compared to WT. The additional β-sheet content is reflected by the low Ea constant naa (mol H2O per mol amino acid residue) or only little raising naa sections in o-m and a-m differences, respectively (Figure 1b). This is supported by the inverse preferences to form helices for alanine and to support β-sheet structures for threonine [46], i.e., A53T αS is more prone to have β-sheets than WT αS. This suggestion is affirmed by the comparison of o-m and a-m differences for the WT and the A53T αS variants (Figure 2).
The WT and the A53T o-m differences are equal in the potential barrier region 5.41 kJ mol−1 ≤ Ea ≤ 5.77 kJ mol−1 (Figure 2a). This region belongs to interactions incorporating the monomers into oligomers or amyloids and to the secondary structures forming in the process of polymerization. The loss of mobile hydration water is the most intensive at potential barrier values near to the melting point of bulk water (6.01 kJ mol−1). The slope of the decrease is less steep in the case of o-m curves than for o-a curves (Figure 1 and Figure 2). In this region, close to the melting point of bulk water, the most strongly bound water molecules start to move. The mobile hydration water loss is the greatest for the a-m curves, here is where we can detect the largest difference compared to the monomers. The monomers lose much more hydration water, which is visible as mobile for NMR, while forming amyloids than in the formation of oligomers. Some of the strong mobile hydration water–protein bonds are disrupted, allowing the protein to form intermolecular connections in the oligomers and amyloids. These new bonds are the ones that hold the oligomers and amyloids together. In the ~5.8 kJ mol−1 to 6.01 kJ mol−1 potential barrier region, A53T αS amyloids lose the most mobile hydration water, Δnaa = 9.8. While the WT αS amyloids lose less mobile hydration water, Δnaa = 7.5. The oligomers make approximately half as much water–protein bonds in their formation, namely Δnaa = 4.9 in the A53T variants and it is Δnaa = 4.0 in the WT αS oligomers. This suggests a more compact form of A53T oligomers, partially explaining why this mutant forms amyloids at a much faster pace than the wild type αS.
The (amyloid–oligomer) mobile hydration difference shows that oligomers are more hydrated than amyloids (Figure 3). As mentioned earlier, this is directly connected to the differences in the compactness of the two protein structures. The difference varies between naa = −0.9 and naa = −1.8, except at 5.85 kJ mol−1 ≤ Ea ≤ 6.01 kJ mol−1, where it extends to as large values as naa ≈ −13. The difference changes more for WT than for A53T αS, the average is −1.40(5) with 0.08 variance for WT αS in the 4.96 kJ mol−1 ≤ Ea ≤ 5.85 kJ mol−1 potential barrier range while the average is −1.27(4) with 0.04 variance for A53T αS in the same energy range. This means an overall more homogeneous solvent accessible surface of A53T αS. It can be the result of the amyloids having smaller solvent accessible surface per monomer units compared to oligomers.

3.2. The Stabilin CTD-Tβ4 System

The number of the intermolecular bonds connecting Tβ4 and stabilin CTD was determined, to build 1:1 protein complex. The mobile hydration values per amino acid residues were simply added together for the constituting proteins at each potential barrier values, i.e., the MDs of these proteins were numerically added. The sum was compared to the measured MD of the 1:1 protein complex (Figure 4). The comparison revealed that the sum is greater than the measured values of the 1:1 complex between 5.40(3) kJ mol−1 ≤ Ea ≤ 5.70(5) kJ mol−1 potential barrier values. Outside of this range, the sum and measured MDs coincide. The difference equals to naa = 0.21(1) or 20(1) H2O/complex and gives the number of mobile hydration water to protein bonds broken by the formation of the 1:1 protein complex. These broken bonds mean interaction sites that then make new intramolecular bonds, which hold the 1:1 protein complex together. The energy of the bonds falls in the potential-barrier interval of the broken bonds.
Given the sizes of the two proteins, the number of intermolecular bonds is low. Since both of the partners are disordered in isolation, this few intramolecular bonds are not capable of restricting the movement of the two proteins, resulting in a fuzzy complex. In this setup, both Tβ4 and stabilin CTD retain most of their structural disorder even in the bound state. Fuzzy complexes, where some level of flexibility is observed after binding, are frequently found in nature [47]. In most cases, when an IDP makes connections with a globular protein, fuzziness is limited to a certain level, but binding of two IDPs can lead to the formation of complexes with extreme fuzziness—where the partners remain mostly disordered [5]. These types of interactions pose a challenge for structural characterization, as most methods are unable to pick up the subtle changes that occur upon binding in such a way. Our results clearly show that Tβ4 and stabilin CTD are capable of interacting with each other and remain almost completely disordered in their complex.

4. Discussion

The A53T mutants have surplus β-sheets to the wild type α-synucleins according to FTIR, ss-NMR and single-molecule force spectroscopy experiments [21,23,24]. In our results, the additional β-sheet content is indicated by the extra low-potential-barrier constant or almost constant MD difference section (Figure 2). The bonds between the monomers in oligomers or amyloids and the secondary structures specific to the aggregates appear as coinciding sections of WT and A53T αSs (thick black lines in the insets of Figure 2). The most strongly bound water molecules start to move close to the melting point of bulk water. Oligomers lose more mobile hydration water than the amyloids as it can be seen on the (amyloid–oligomer) hydration difference. On place of the lost protein–water bonds, new intermolecular connections form during aggregation, which bond the monomers into oligomers or amyloids. The A53T oligomers are more compact than the WT ones according to the (amyloid–oligomer) MD differences (Figure 3). This compactness partially gives reason the mutant to form amyloids faster. The oligomers are more hydrated as a result. The A53T αS has more homogeneous solvent accessible surface per monomer units compared to WT αS because, e.g., the mobile hydration in the (amyloid–oligomer) MD differences are smaller with half as big variance. The (amyloid–oligomer) MD differences being negative, reflect the amyloids having smaller solvent accessible surface per monomer units compared to oligomers.
The sum of the MDs of the proteins Tβ4 and stabilin CTD is greater than the measured MD of the 1:1 protein complex by naa = 0.21(1) or 20(1) H2O/complex (Figure 4). The Tβ4 and stabilin CTD interact with each other while remain almost completely disordered in their complex. Binding of two IDPs like Tβ4 and stabilin CTD leads to the formation of a complex with extreme fuzziness [5], the partner proteins remain disordered in the complex. Both constituting proteins in the 1:1 complex retain most of their structural disorder. Tβ4 and stabilin CTD connect to each other with only a small number of intermolecular bonds. The intermolecular bonds are not enough numerous to limit the movement of the two proteins in the complex.

5. Conclusions

Mobile hydration differences (monomer MD subtracted from oligomer and amyloid MDs) were calculated for αS variants of different polymerization degrees. The derivative ratios of the MDs reflect very sensitively the changes in the trends of the melting curves, and they have characteristically different shapes for the WT and the A53T variants. The constant low Ea sections in A53T αS difference curves for oligomers and amyloids are caused by the excess β-sheet contents of the mutant compared to WT. The 5.41 kJ mol−1 ≤ Ea ≤ 5.77 kJ mol−1 difference MD regions belong to interactions linking the monomers into oligomers or amyloids and to the bonds of secondary structures forming in the process of polymerization. The monomers lose much more mobile hydration water while forming amyloids than in the formation of oligomers, reflecting fundamental structural differences between oligomers and amyloids. A part of the strong mobile hydration water–protein bonds are lost and these bonding sites of the protein form intermolecular bonds in the oligomers and amyloids. The new bonds being created connect the constituting proteins into oligomers or amyloids. The amyloid–oligomer difference MD showed that there is an overall more homogeneous solvent accessible surface of A53T αS amyloids than the WT variants, suggesting a more densely packed amyloid structure.
We gained information on the intermolecular bonds constructing the αS oligomer and amyloid aggregates from the monomers.
The number of the intermolecular bonds was determined, which connect Tβ4 and stabilin CTD in the thymosin-β4–stabilin-2 CTD complex. It was found that there are naa = 0.21(1) or 20(1) H2O/complex such bonds and their bonding energy falls into the 5.40 kJ mol−1 ≤ Ea ≤ 5.70 kJ mol−1 range. These results were gained from the comparison of the nominal sum of the MDs of the constituting proteins to the measured MD of the thymosin-β4–stabilin-2 CTD complex and provide further insight into the molecular background of their fuzzy complexes.

Author Contributions

Conceptualization, M.B. and Á.T.; methodology, M.B.; validation, M.B. and Á.T.; formal analysis, M.B.; investigation, M.B.; data curation, M.B.; writing—original draft preparation, M.B. and Á.T.; writing—review and editing, M.B. and Á.T.; visualization, M.B.; supervision, M.B.; funding acquisition, Á.T. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by National Research, Development and Innovation Office, Hungary grant number K-125340 (Á.T.). Wigner Research Centre for Physics covered publication costs.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Acknowledgments

Kaálmaán Tompa is gratefully thanked for his support.

Conflicts of Interest

The authors declare no conflict of interest.

Appendix A

Wide-Line 1H NMR-Spectrometry

Frozen protein solutions are measured with wide-line 1H NMR to get melting diagrams in the temperature range from −70 °C to +20 °C. The free induction decay (FID) signal can be separated into differently decaying components. The slowly decaying component is generated by the 1H nuclei of the mobile hydration water. The extrapolated amplitude to time zero of each FID-component is proportional to the amount of each 1H fraction.
The mobile water molecules are found at the surface of the protein molecules. The melting diagram gives the amount of mobile water measured by NMR as a function of temperature. The corresponding potential barrier values to temperature, Ea are given as the normalized fundamental temperature multiplied with the molar heat of fusion for water (Ea = T/273.15 K × 6.01 kJ mol−1, normalized fundamental temperature is multiplied with the molar heat of fusion of water [48]), thus providing an energy scale.
The amount of mobile, i.e., molten water is measured directly as a fraction of the total water content of the protein solution, n vs. T. It is converted into the number of mobile water molecules per amino acid residue, naa. The naa vs. Ea data can provide quantitative analysis beyond spectroscopy.
The melting curve can be formally described as a series expansion (Supporting Information of [5]),
n ( T f n ) = A + B ( T f n − T f n 1 ) + C ( T f n − T f n 2 ) 2 + D ( T f n − T f n 3 ) 3 + …
The parameter Tfn1 gives the temperature where the thermal trend of the MD switches between constant and linearly increasing. Likewise, the trend changes from linear to quadratic at Tfn2 and it becomes cubic at Tfn3.
The fitting procedure is carried out in sections. It starts with the lowest temperatures. If there is a constant n region, then the values of A are determined and kept for further analysis. Then, follows the linear section and parameters B and Tfn1 are gained and used in sections of higher powers. The next section is increasing quadratically and C and Tfn2 is fitted, then the cubic section is next with D and Tfn3.

References

  1. Tompa, P.; Schad, E.; Tantos, A.; Kalmar, L. Intrinsically disordered proteins: Emerging interaction specialists. Curr. Opin. Struct. Biol. 2015, 35, 49–59. [Google Scholar] [CrossRef]
  2. Hazy, E.; Bokor, M.; Kalmar, L.; Gelencser, A.; Kamasa, P.; Han, K.-H.; Tompa, K.; Tompa, P. Distinct Hydration Properties of Wild-Type and Familial Point Mutant A53T of α-Synuclein Associated with Parkinson’s Disease. Biophys. J. 2011, 101, 2260–2266. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Bokor, M.; Tantos, Á.; Tompa, P.; Han, K.-H.; Tompa, K. WT and A53T α-Synuclein Systems: Melting Diagram and Its New Interpretation. Int. J. Mol. Sci. 2020, 21, 3997. [Google Scholar] [CrossRef] [PubMed]
  4. Tantos, A.; Szabó, B.; Láng, A.; Varga, Z.; Tsylonok, M.; Bokor, M.; Verebelyi, T.; Kamasa, P.; Tompa, K.; Perczel, A.; et al. Multiple fuzzy interactions in the moonlighting function of thymosin-β4. Intrinsically Disord. Proteins 2013, 1, e26204. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Bokor, M.; Tantos, Á.; Mészáros, A.; Jenei, B.; Haminda, R.; Tompa, P.; Tompa, K. Molecular Motions and Interactions in Aqueous Solutions of Thymosin-β 4, Stabilin CTD and Their 1: 1 Complex, Studied by 1 H-NMR Spectroscopy. ChemPhysChem 2020, 21, 1420–1428. [Google Scholar] [CrossRef] [PubMed]
  6. Goedert, M. Alpha-synuclein and neurodegenerative diseases. Nat. Rev. Neurosci. 2001, 2, 492–501. [Google Scholar] [CrossRef]
  7. Scott, D.; Roy, S. -Synuclein Inhibits Intersynaptic Vesicle Mobility and Maintains Recycling-Pool Homeostasis. J. Neurosci. 2012, 32, 10129–10135. [Google Scholar] [CrossRef] [Green Version]
  8. Sun, J.; Wang, L.; Bao, H.; Premi, S.; Das, U.; Chapman, E.R.; Roy, S. Functional cooperation of α-synuclein and VAMP2 in synaptic vesicle recycling. Proc. Natl. Acad. Sci. USA 2019, 116, 11113–11115. [Google Scholar] [CrossRef] [Green Version]
  9. Jo, E.; Fuller, N.; Rand, R.; George-Hyslop, P.S.; Fraser, P.E. Defective membrane interactions of familial Parkinson’s disease mutant A30P α-synuclein. J. Mol. Biol. 2002, 315, 799–807. [Google Scholar] [CrossRef]
  10. Spira, P.J.; Sharpe, D.M.; Halliday, G.; Cavanagh, J.; Nicholson, G.A. Clinical and pathological features of a parkinsonian syndrome in a family with an Ala53Thr ?-synuclein mutation. Ann. Neurol. 2001, 49, 313–319. [Google Scholar] [CrossRef]
  11. Marchalonis, J. Lymphocyte surface immunoglobulins. Science 1975, 190, 20–29. [Google Scholar] [CrossRef]
  12. Burré, J.; Sharma, M.; Südhof, T.C. Definition of a Molecular Pathway Mediating -Synuclein Neurotoxicity. J. Neurosci. 2015, 35, 5221–5232. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Outeiro, T.F.; Putcha, P.; Tetzlaff, J.E.; Spoelgen, R.; Koker, M.; Carvalho, F.; Hyman, B.T.; McLean, P.J. Formation of Toxic Oligomeric α-Synuclein Species in Living Cells. PLoS ONE 2008, 3, e1867. [Google Scholar] [CrossRef]
  14. Winner, B.; Jappelli, R.; Maji, S.K.; Desplats, P.A.; Boyer, L.; Aigner, S.; Hetzer, C.; Loher, T.; Vilar, M.; Campioni, S.; et al. In vivo demonstration that -synuclein oligomers are toxic. Proc. Natl. Acad. Sci. USA 2011, 108, 4194–4199. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Cremades, N.; Cohen, S.I.; Deas, E.; Abramov, A.Y.; Chen, A.Y.; Orte, A.; Sandal, M.; Clarke, R.W.; Dunne, P.; Aprile, F.A.; et al. Direct Observation of the Interconversion of Normal and Toxic Forms of α-Synuclein. Cell 2012, 149, 1048–1059. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Prots, I.; Veber, V.; Brey, S.; Campioni, S.; Buder, K.; Riek, R.; Böhm, K.J.; Winner, B. α-Synuclein Oligomers Impair Neuronal Microtubule-Kinesin Interplay. J. Biol. Chem. 2013, 288, 21742–21754. [Google Scholar] [CrossRef] [Green Version]
  17. Dunker, A.K.; Silman, I.; Uversky, V.N.; Sussman, J.L. Function and structure of inherently disordered proteins. Curr. Opin. Struct. Biol. 2008, 18, 756–764. [Google Scholar] [CrossRef]
  18. Mor, D.E.; Ugras, S.E.; Daniels, M.J.; Ischiropoulos, H. Dynamic structural flexibility of α-synuclein. Neurobiol. Dis. 2016, 88, 66–74. [Google Scholar] [CrossRef] [Green Version]
  19. Minde, D.-P.; Dunker, A.K.; Lilley, K.S. Time, space, and disorder in the expanding proteome universe. Proteome 2017, 17, 1600399. [Google Scholar] [CrossRef]
  20. Chen, J.; Kriwacki, R.W. Intrinsically Disordered Proteins: Structure, Function and Therapeutics. J. Mol. Biol. 2018, 430, 2275–2277. [Google Scholar] [CrossRef]
  21. Li, J.; Uversky, V.N.; Fink, A.L. Conformational Behavior of Human α-Synuclein is Modulated by Familial Parkinson’s Disease Point Mutations A30P and A53T. NeuroToxicology 2002, 23, 553–567. [Google Scholar] [CrossRef]
  22. Conway, K.A.; Harper, J.D.; Lansbury, P.T. Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease. Nat. Med. 1998, 4, 1318–1320. [Google Scholar] [CrossRef] [PubMed]
  23. Heise, H.; Celej, M.S.; Becker, S.; Riedel, D.; Pelah, A.; Kumar, A.; Jovin, T.M.; Baldus, M. Solid-State NMR Reveals Structural Differences between Fibrils of Wild-Type and Disease-Related A53T Mutant α-Synuclein. J. Mol. Biol. 2008, 380, 444–450. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Brucale, M.; Sandal, M.; Di Maio, S.; Rampioni, A.; Tessari, I.; Tosatto, L.; Bisaglia, M.; Bubacco, L.; Samorì, B. Pathogenic Mutations Shift the Equilibria of α-Synuclein Single Molecules towards Structured Conformers. ChemBioChem 2009, 10, 176–183. [Google Scholar] [CrossRef]
  25. Giasson, B.I.; Uryu, K.; Trojanowski, J.Q.; Lee, V.M.-Y. Mutant and Wild Type Human α-Synucleins Assemble into Elongated Filaments with Distinct Morphologies in Vitro. J. Biol. Chem. 1999, 274, 7619–7622. [Google Scholar] [CrossRef] [Green Version]
  26. Bertoncini, C.W.; Jung, Y.-S.; Fernandez, C.O.; Hoyer, W.; Griesinger, C.; Jovin, T.M.; Zweckstetter, M. From the Cover: Release of long-range tertiary interactions potentiates aggregation of natively unstructured -synuclein. Proc. Natl. Acad. Sci. USA 2005, 102, 1430–1435. [Google Scholar] [CrossRef] [Green Version]
  27. Narhi, L.; Wood, S.J.; Steavenson, S.; Jiang, Y.; Wu, G.M.; Anafi, D.; Kaufman, S.A.; Martin, F.; Sitney, K.; Denis, P.; et al. Both Familial Parkinson’s Disease Mutations Accelerate α-Synuclein Aggregation. J. Biol. Chem. 1999, 274, 9843–9846. [Google Scholar] [CrossRef] [Green Version]
  28. Coskuner, O.; Wise-Scira, O. Structures and Free Energy Landscapes of the A53T Mutant-Type α-Synuclein Protein and Impact of A53T Mutation on the Structures of the Wild-Type α-Synuclein Protein with Dynamics. ACS Chem. Neurosci. 2013, 4, 1101–1113. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Serpell, L.C.; Berriman, J.; Jakes, R.; Goedert, M.; Crowther, R.A. Fiber diffraction of synthetic alpha -synuclein filaments shows amyloid-like cross-beta conformation. Proc. Natl. Acad. Sci. USA 2000, 97, 4897–4902. [Google Scholar] [CrossRef] [Green Version]
  30. Kamiyoshihara, T.; Kojima, M.; Ueda, K.; Tashiro, M.; Shimotakahara, S. Observation of multiple intermediates in α-synuclein fibril formation by singular value decomposition analysis. Biochem. Biophys. Res. Commun. 2007, 355, 398–403. [Google Scholar] [CrossRef]
  31. Lashuel, H.A.; Petre, B.M.; Wall, J.; Simon, M.; Nowak, R.J.; Walz, T.; Lansbury, P.T. α-Synuclein, Especially the Parkinson’s Disease-associated Mutants, Forms Pore-like Annular and Tubular Protofibrils. J. Mol. Biol. 2002, 322, 1089–1102. [Google Scholar] [CrossRef] [Green Version]
  32. Conway, K.A.; Lee, S.-J.; Rochet, J.-C.; Ding, T.T.; Williamson, R.E.; Lansbury, P.T. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha -synuclein mutations linked to early-onset Parkinson’s disease: Implications for pathogenesis and therapy. Proc. Natl. Acad. Sci. USA 2000, 97, 571–576. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Ono, K.; Ikeda, T.; Takasaki, J.-I.; Yamada, M. Familial Parkinson disease mutations influence α-synuclein assembly. Neurobiol. Dis. 2011, 43, 715–724. [Google Scholar] [CrossRef]
  34. Gallardo, R.; Ranson, N.A.; Radford, S.E. Amyloid structures: Much more than just a cross-β fold. Curr. Opin. Struct. Biol. 2020, 60, 7–16. [Google Scholar] [CrossRef] [PubMed]
  35. Hoshino, M. Fibril formation from the amyloid-β peptide is governed by a dynamic equilibrium involving association and dissociation of the monomer. Biophys. Rev. 2017, 9, 9–16. [Google Scholar] [CrossRef] [Green Version]
  36. Tipping, K.W.; Karamanos, T.K.; Jakhria, T.; Iadanza, M.G.; Goodchild, S.C.; Tuma, R.; Ranson, N.A.; Hewitt, E.W.; Radford, S.E. pH-induced molecular shedding drives the formation of amyloid fibril-derived oligomers. Proc. Natl. Acad. Sci. USA 2015, 112, 5691–5696. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Safer, D.; Elzinga, M.; Nachmias, V.T. Thymosin β4 and Fx, an actin-sequestering peptide, are indistinguishable. J. Biol. Chem. 1991, 266, 4029–4032. [Google Scholar] [CrossRef]
  38. Yarmola, E.G.; Klimenko, E.S.; Fujita, G.; Bubb, M.R. Thymosin beta4: Actin Regulation and More. Ann. N. Y. Acad. Sci. 2007, 1112, 76–85. [Google Scholar] [CrossRef]
  39. Grant, D.S.; Rose, W.; Yaen, C.; Goldstein, A.; Martinez, J.; Kleinman, H. Thymosin β4 enhances endothelial cell differentiation and angiogenesis. Angiogenesis 1999, 3, 125–135. [Google Scholar] [CrossRef]
  40. Smart, N.; Rossdeutsch, A.; Riley, P.R. Thymosin β4 and angiogenesis: Modes of action and therapeutic potential. Angiogenesis 2007, 10, 229–241. [Google Scholar] [CrossRef]
  41. Qiu, P.; Sosne, G.; Kurpakus-Wheater, M. Matrix metalloproteinase activity is necessary for thymosin beta 4 promotion of epithelial cell migration. J. Cell. Physiol. 2007, 212, 165–173. [Google Scholar] [CrossRef] [PubMed]
  42. Domanski, M.; Hertzog, M.; Coutant, J.; Gutsche-Perelroizen, I.; Bontems, F.; Carlier, M.-F.; Guittet, E.; van Heijenoort, C. Coupling of Folding and Binding of Thymosin β4 upon Interaction with Monomeric Actin Monitored by Nuclear Magnetic Resonance. J. Biol. Chem. 2004, 279, 23637–23645. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Hertzog, M.; van Heijenoort, C.; Didry, D.; Gaudier, M.; Coutant, J.; Gigant, B.; Didelot, G.; Préat, T.; Knossow, M.; Guittet, E.; et al. The β-Thymosin/WH2 Domain: Structural Basis for the Switch from Inhibition to Promotion of Actin Assembly. Cell 2004, 117, 611–623. [Google Scholar] [CrossRef]
  44. Ho, J.H.-C.; Tseng, K.-C.; Ma, W.-H.; Chen, K.-H.; Lee, O.K.-S.; Su, Y. Thymosin beta-4 upregulates anti-oxidative enzymes and protects human cornea epithelial cells against oxidative damage. Br. J. Ophthalmol. 2008, 92, 992–997. [Google Scholar] [CrossRef] [PubMed]
  45. Lee, S.-J.; So, I.-S.; Park, S.-Y.; Kim, I.-S. Thymosin β4 is involved in stabilin-2-mediated apoptotic cell engulfment. FEBS Lett. 2008, 582, 2161–2166. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Podoly, E.; Hanin, G.; Soreq, H. Alanine-to-threonine substitutions and amyloid diseases: Butyrylcholinesterase as a case study. Chem. Interac. 2010, 187, 64–71. [Google Scholar] [CrossRef] [PubMed]
  47. Wang, W.; Wang, D. Extreme Fuzziness: Direct Interactions between Two IDPs. Biomolecules 2019, 9, 81. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  48. CRC. Handbook of Chemistry and Physics, 101st ed.; CRC Press: Boca Raton, FL, USA, 2020; ISBN 9780367417246. [Google Scholar]
Biomolecules 11 00757 g001 550
Figure 1. (a) Wild type α-synuclein, oligomer-monomer (grey) and amyloid–monomer (blue) melting diagrams; (b) A53T α-synuclein, oligomer–monomer (red) and amyloid–monomer (green) melting diagrams. Mol H2O per mol amino acid residue (naa) vs. potential barrier. Lines are guides to the eye. The insets are the derivative forms of the difference melting diagrams. Mol H2O per mol amino acid residue (naa) vs. potential barrier. Lines are guides to the eye. The insets are the derivative forms of the difference melting diagrams.
Figure 1. (a) Wild type α-synuclein, oligomer-monomer (grey) and amyloid–monomer (blue) melting diagrams; (b) A53T α-synuclein, oligomer–monomer (red) and amyloid–monomer (green) melting diagrams. Mol H2O per mol amino acid residue (naa) vs. potential barrier. Lines are guides to the eye. The insets are the derivative forms of the difference melting diagrams. Mol H2O per mol amino acid residue (naa) vs. potential barrier. Lines are guides to the eye. The insets are the derivative forms of the difference melting diagrams.
Biomolecules 11 00757 g001
Biomolecules 11 00757 g002 550
Figure 2. (a) Oligomer-monomer melting diagrams for wild type (grey) and A53T (red) α-synuclein; (b) Amyloid-monomer melting diagrams for wild type (blue) and A53T (green) α-synuclein. Mol H2O per mol amino acid residue (naa) vs. potential barrier. Lines are guides to the eye. The insets are the derivative forms of the difference melting diagrams. The thick black lines denote the common sections on the derivative melting diagrams.
Figure 2. (a) Oligomer-monomer melting diagrams for wild type (grey) and A53T (red) α-synuclein; (b) Amyloid-monomer melting diagrams for wild type (blue) and A53T (green) α-synuclein. Mol H2O per mol amino acid residue (naa) vs. potential barrier. Lines are guides to the eye. The insets are the derivative forms of the difference melting diagrams. The thick black lines denote the common sections on the derivative melting diagrams.
Biomolecules 11 00757 g002
Biomolecules 11 00757 g003 550
Figure 3. Wild type (red triangles) and A53T (blue triangles) α-synuclein amyloid-oligomer difference melting diagrams. Mol H2O per mol amino acid residue (naa) vs. potential barrier.
Figure 3. Wild type (red triangles) and A53T (blue triangles) α-synuclein amyloid-oligomer difference melting diagrams. Mol H2O per mol amino acid residue (naa) vs. potential barrier.
Biomolecules 11 00757 g003
Biomolecules 11 00757 g004 550
Figure 4. Sum of the measured melting diagrams of isolated thymosin-β4 and stabilin-2 CTD (blue circles). Measured melting diagram of thymosin-β4--stabilin-2 CTD complex (magenta circles). Their difference is given by black stars and line. Inset: whole potential barrier range from the no mobile hydration water point to the melting point of water.
Figure 4. Sum of the measured melting diagrams of isolated thymosin-β4 and stabilin-2 CTD (blue circles). Measured melting diagram of thymosin-β4--stabilin-2 CTD complex (magenta circles). Their difference is given by black stars and line. Inset: whole potential barrier range from the no mobile hydration water point to the melting point of water.
Biomolecules 11 00757 g004
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Bokor, M.; Tantos, Á. Protein–Protein Connections—Oligomer, Amyloid and Protein Complex—By Wide Line 1H NMR. Biomolecules 2021, 11, 757. https://doi.org/10.3390/biom11050757

AMA Style

Bokor M, Tantos Á. Protein–Protein Connections—Oligomer, Amyloid and Protein Complex—By Wide Line 1H NMR. Biomolecules. 2021; 11(5):757. https://doi.org/10.3390/biom11050757

Chicago/Turabian Style

Bokor, Mónika, and Ágnes Tantos. 2021. "Protein–Protein Connections—Oligomer, Amyloid and Protein Complex—By Wide Line 1H NMR" Biomolecules 11, no. 5: 757. https://doi.org/10.3390/biom11050757

APA Style

Bokor, M., & Tantos, Á. (2021). Protein–Protein Connections—Oligomer, Amyloid and Protein Complex—By Wide Line 1H NMR. Biomolecules, 11(5), 757. https://doi.org/10.3390/biom11050757

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop